Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis
NCT: NCT06401928 · COMPLETED
Brief Summary
Multiple Sclerosis (MS) is an autoimmune disease associated with physical disability, psychological impairment, and cognitive dysfunction. As a result, the disease burden is high, and treatment options are limited. In this randomized, double-blind study, the investigators planned to use repeated electrical stimulation and assess mental health-related variables (e.g., quality of life, sleep, psychological distress) and cognitive dysfunction in patients with MS.
Frequently Asked Questions
What is Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis?
Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis is a clinical trial registered under NCT06401928. Current status: COMPLETED.
What is the status of NCT06401928?
The current status of NCT06401928 (Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis) is: COMPLETED.
When did Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis start?
Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis started on 2023-02-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.